Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma(Montreal Neurological Institute and Hospital), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Christopher G. Goetz(Rush University Medical Center), Ian O. Bledsoe(University of California, San Francisco), Silvia Ríos‐Romenets(Montreal General Hospital), Glenda M. Halliday(UNSW Sydney), Piu Chan(Capital Medical University), Corina Maetzler(Christian-Albrechts-Universität zu Kiel), Werner Poewe(University of Verona), Beatrice Heim(Innsbruck Medical University), Elizabeth Slow(Toronto Western Hospital), Taomian Mi(Capital Medical University), Simon J.G. Lewis(School of the Art Institute of Chicago), Klaus Seppi(Innsbruck Medical University), Yuan Li(Capital Medical University), Anthony E. Lang(Unknown), Eva Schäffer, Irene Litvan(Johns Hopkins University)
Cited by 299
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k